December 11, 2006 — The US Food and Drug Administration (FDA) has approved a polytetrafluoroethylene-heparin vascular graft for use in the treatment of peripheral artery disease, a myocardial ...
Efficacy and safety of the anti–PD-L1 monoclonal antibody socazolimab for recurrent or metastatic cervical cancer: Results from the phase I dose-escalation and expansion study. This is an ASCO Meeting ...
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has received notification that CE Mark approval has been granted for LuViva ® Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback